Brief: Nextcure Inc Provides An Update On Clinical Trial Program For Nc318
Dec 17 (Reuters) - NextCure Inc NXTC.O :
* NEXTCURE INC - PROVIDED AN UPDATE ON CLINICAL TRIAL
PROGRAM FOR
NC318
* NEXTCURE INC - NO LONGER PLANS TO INITIATE A STUDY OF
NC318 IN
COMBINATION WITH CHEMOTHERAPY.
Source text for Eikon: ID:nGNXbFv4dh
Further company coverage: NXTC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NextCure
See all newsBrief: Xcellon Biologics Co Acquires Gmp Manufacturing Facility From Nextcure
NextCure Inc reports results for the quarter ended June 30 - Earnings Summary
NextCure Q2 net loss narrows on lower expenses
Brief: NextCure Q2 Net Income USD -14.892 Million
NextCure Inc expected to post a loss of $1.93 a share - Earnings Preview